ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of ...
ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency ...
AIX-EN-PROVENCE, France--(BUSINESS WIRE)--After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the DDW Convention in San Diego and the EASL Conference in ...
Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...
Hepatitis C can be cured in almost all cases with modern medication. However, if advanced liver damage is already present at the time of cure, there is still a residual risk of liver cancer and ...
Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...
On Thursday, the Food and Drug Administration announced its approval of the first ever therapeutic treatment targeting metabolic dysfunction-associated steatohepatitis (MASH). This represents a ...
A research team from the Department of Medicine III at MedUni Vienna and University Hospital Vienna has conducted a large-scale study showing the important value of repeated liver assessments by a ...
A research team from the Department of Medicine III at MedUni Vienna and University Hospital Vienna has conducted a large-scale study showing the important value of repeated liver assessments by a ...
New European and Latin American guidelines on the use of noninvasive tests for liver evaluation are the first to specifically address an approach that has become the standard in much of the developed ...
Higher TSH levels and lower T3 levels may predict liver outcomes and % MACE risk among individuals with MASLD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results